Antiarrhythmic (Class IC)Conditionally Approved

Flecainide

Brand names: Tambocor|Last verified: 2026-03-01

FAA Pathway: Special Issuance required — cardiac evaluation mandatory

Flecainide requires Special Issuance evaluation. Used for atrial fibrillation and supraventricular tachycardia, the underlying arrhythmia and the medication's proarrhythmic potential both require thorough cardiac evaluation.

Check your medications

Look up any medication in our FAA compatibility database.

Medication Checker

Pilot Tip

Always report all medications on your FAA medical application (Form 8500-8, Item 17a), even OTC medications. Failure to disclose is a far bigger issue than the medication itself.

Certification Details

Key Requirements
Cardiac evaluation, Holter monitoring, stress test
Certificate Classes
May be eligible with cardiac documentation
Monitoring
Regular ECG and cardiac rhythm monitoring
Notes
Proarrhythmic risk must be documented as acceptable

Sources

  • FAA AME Guide, Cardiology

Last verified: 2026-03-01

Frequently Asked Questions

Is Flecainide allowed for pilots?

The FAA considers Flecainide (Tambocor) to be "Conditionally Approved" for medical certification purposes. Flecainide requires Special Issuance evaluation. Used for atrial fibrillation and supraventricular tachycardia, the underlying arrhythmia and the medication's proarrhythmic potential both require thorough cardiac evaluation.

What is the FAA status of Flecainide?

Flecainide has a status of "Conditionally Approved" under FAA medical certification policy. The certification pathway is: Special Issuance required — cardiac evaluation mandatory.

Can I fly while taking Flecainide?

Flying while taking Flecainide may be possible through the FAA's Special Issuance process. You will need to meet specific requirements and obtain approval before exercising pilot privileges. Consult an experienced AME for guidance.

Important Notice

The FAA does not publish a comprehensive list of “approved” medications. The information on this page represents our interpretation of publicly available FAA guidance and is provided for informational and educational purposes only. It does not constitute medical advice, legal advice, or a guarantee of certification outcome.

The primary issue with the FAA is always whether the underlying medical condition — not just the medication — is compatible with safe flight. You should only start, stop, or change medications after consulting your treating physician. Always consult with a qualified Aviation Medical Examiner (AME) for guidance specific to your situation. FAA policies are subject to change. ClearedMed is not affiliated with or endorsed by the FAA.